Patents Assigned to Aventis Pasteur Limited/Aventis Pasteur Limitee
  • Chlamydia antigens and corresponding DNA fragments and uses thereof
    Patent number: 6607730
    Abstract: In summary of this disclosure, the present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector, containing a nucleotide sequence encoding an POMP91B precursor protein of a strain of Chlamydia pneumoniae and a promoter to effect expression of the POMP91B precursor gene in the host. Modifications are possible within the scope of this invention.
    Type: Grant
    Filed: October 29, 1999
    Date of Patent: August 19, 2003
    Assignee: Aventis Pasteur Limited/Aventis Pasteur Limitee
    Inventors: Andrew D. Murdin, Raymond P. Oomen, Pamela L. Dunn
  • CHLAMYDIA ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
    Publication number: 20030147924
    Abstract: In summary of this disclosure, the present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae, employing a vector, containing a nucleotide sequence encoding a CPN100149 polypeptide of a strain of Chlamydia pneumoniae and a promoter to effect expression of the CPN100149 polypeptide in the host. Modifications are possible within the scope of this invention.
    Type: Application
    Filed: July 26, 1999
    Publication date: August 7, 2003
    Applicant: AVENTIS PASTEUR LIMITED/AVENTIS PASTEUR LIMITEE
    Inventors: ANDREW D. MURDIN, RAYMOND P. OOMEN